High expression levels of COX-2 and P300 are associated with unfavorable survival in laryngeal squamous cell carcinoma

European Archives of Oto-Rhino-Laryngology

Volumn 270, Issue 3, 2013, Pages 1009-1017

  Chen, Yan Feng ^a   Luo, Rong Zhen ^a   Li, Yong ^a   Cui, Bo Kang ^a   Song, Ming ^a   Yang, An Kui ^a   Chen, Wen Kuan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

COX 2; Laryngeal squamous cell carcinoma (LSCC); P300; Prognosis; Survival

Indexed keywords

CYCLOOXYGENASE 2; E1A ASSOCIATED P300 PROTEIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL FEATURE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TISSUE MICROARRAY;

CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; E1A-ASSOCIATED P300 PROTEIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS;

EID: 84878352388     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-012-2275-1     Document Type: Article

References (30)

1. Smith WL, Garavito RM, DeWitt DL (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271(52):33157-33160
2. Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP, Tanabe T, Inoue H, Dannenberg AJ (1997) Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. Cancer Res 57(14):2890-2895
3. Morita Y, Hata K, Nakanishi M, Nishisho T, Yura Y, Yoneda T (2012) Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma. Int J Oncol 41(3):885-892
4. Takatori H, Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Sasaki K, Tamotsu K, Owaki T, Ishigami S, Aikou T (2008) Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma. Eur J Surg Oncol 34(4):397-402
5. Grudzinski M, Cambruzzi E, Lahude E, Savaris RF, Pedrini JL, Zettler CG (2006) Cox-2 and CD105 expression in breast cancer and disease-free survival. Rev Assoc Med Bras 52(4):275-280
6. Chan HM, La Thangue NB (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 114(Pt 13):2363-2373
7. Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG (2007) Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis. Cell Res 17(4):324-332
8. Ishihama K, Yamakawa M, Semba S, Takeda H, Kawata S, Kimura S, Kimura W (2007) Expression of HDAC1 and CBP/p300 in human colorectal carcinomas. J Clin Pathol 60(11):1205-1210
9. Green AR, Burney C, Granger CJ, Paish EC, El-Sheikh S, Rakha EA, Powe DG, Macmillan RD, Ellis IO, Stylianou E (2008) The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome. Breast Cancer Res Treat 110(3):427-437
10. Isharwal S, Miller MC, Marlow C, Makarov DV, Partin AW, Veltri RW (2008) p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape. Prostate 68(10):1097-1104
11. Zhang C, Li K, Wei L, Li Z, Yu P, Teng L, Wu K, Zhu J (2007) p300 expression repression by hypermethylation associated with tumour invasion and metastasis in oesophageal squamous cell carcinoma. J Clin Pathol 60(11):1249-1253
12. Xiao X, Shi D, Liu L, Wang J, Xie X, Kang T, Deng W (2011) Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. PLoS One 6(8):e22934
13. Tsujii M, DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83(3):493-501
14. Sayar C, Sayar H, Ozdemir S, Selçuk T, Görgülü O, Akbaş Y, Kemal Olgun M (2012) Cyclooxygenase-2 expression and clinical parameters in laryngeal squamous cell carcinoma, vocal fold nodule, and laryngeal atypical hyperplasia. Head Neck. doi: 10.1002/hed.22911
15. Sun X, Ge R, Dong Q, Zheng C (2005) The expression of cyclooxygenase-2 in laryngeal squamous cell carcinoma and its relationship with MVD. Lin Chuang Er Bi Yan Hou Ke Za Zhi 19(21):967-970
16. Turnell AS, Mymryk JS (2006) Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation. Br J Cancer 95(5):555-560
17. Byun JS, Wong MM, Cui W, Idelman G, Li Q, De Siervi A, Bilke S, Haggerty CM, Player A, Wang YH, Thirman MJ, Kaberlein JJ, Petrovas C, Koup RA, Longo D, Ozato K, Gardner K (2009) Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes. Proc Natl Acad Sci USA 106(46):19286-19291
18. Guermah M, Palhan VB, Tackett AJ, Chait BT, Roeder RG (2006) Synergistic functions of SII and p300 in productive activator-dependent transcription of chromatin templates. Cell 125(2):275-286
19. Janknecht R (2002) The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease. Histol Histopathol 17(2):657-668
20. Liao ZW, Zhou TC, Tan XJ, Song XL, Liu Y, Shi XY, Huang WJ, Du LL, Tu BJ, Lin XD (2012) High expression of p300 is linked to aggressive features and poor prognosis of Nasopharyngeal Carcinoma. J Transl Med 10(1):110
21. Li Y, Yang HX, Luo RZ, Zhang Y, Li M, Wang X, Jia WH (2011) High expression of p300 has an unfavorable impact on survival in resectable esophageal squamous cell carcinoma. Ann Thorac Surg 91(5):1531-1538
22. Chen YF, Chen FJ, Yang AK, Zeng ZY, Song M, Li QL (2004) Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma]. Ai Zheng 23(5):584-588
23. Meyer S, Fuchs TJ, Bosserhoff AK, Hofstädter F, Pauer A, Roth V, Buhmann JM, Moll I, Anagnostou N, Brandner JM, Ikenberg K, Moch H, Landthaler M, Vogt T, Wild PJ (2012) A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One 7(6):e38222
24. Chang BW, Kim DH, Kowalski DP, Burleson JA, Son YH, Wilson LD, Haffty BG (2004) Prognostic significance of cyclooxygenase-2 in oropharyngeal squamous cell carcinoma. Clin Cancer Res 10(5):1678-1684
25. Park BW, Park S, Park HS, Koo JS, Yang WI, Lee JS, Hwang H, Kim SI, Lee KS (2012) Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes. Breast Cancer Res Treat 133(2):741-751
26. Atula T, Hedström J, Ristimäki A, Finne P, Leivo I, Markkanen-Leppänen M, Haglund C (2006) Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome. Oncol Rep 16(3):485-490
27. Shah S, Prasad S, Knudsen KE (2012) Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression. Cancer Res 72(5):1248-1259
28. Wang J, Xiao X, Zhang Y, Shi D, Chen W, Fu L, Liu L, Xie F, Kang T, Huang W, Deng W (2012) Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells. J Pineal Res. doi: 10.1111/j.1600-079X.2012.00973.x
29. Takeuchi A, Shiota M, Tatsugami K, Yokomizo A, Tanaka S, Kuroiwa K, Eto M, Naito S (2012) p300 mediates cellular resistance to doxorubicin in bladder cancer. Mol Med Report 5(1):173-176
30. Wang YH, Wu MW, Yang AK, Zhang WD, Sun J, Liu TR, Chen YF (2011) COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway. Med Oncol 28(Suppl 1):S360-S366